A group of UC San Diego alumni have created a venture capital fund—the Triton Technology Fund—that is specifically focused on commercializing innovations by UC San Diego faculty, students and alumni. The fund will offer an additional option for UC San Diego innovators looking for the investment and expertise that is often crucial for successful technology commercialization.
Gigantic corpse flowers take their name from the rotting stench they emit when they bloom – a two-day spectacle that only happens every few years. Very few of us will ever see or smell one in person. But in a UC San Diego department of visual arts research lab, artist MR Barnadas is creating life-size models of two varieties of the plant, which can grow to 10 feet tall or more.
A team of UC San Diego biologists and engineers has developed a "rapid and tunable post-translational coupling for genetic circuits."
The difference between an immune response that kills cancer cells and one that conversely stimulates tumor growth can be as narrow as a “double-edged sword,” report researchers at the University of California, San Diego School of Medicine in the April 7, 2014 online issue of the Proceedings of the National Academy of Sciences.
The San Diego Supercomputer Center (SDSC) at the University of California, San Diego, has implemented a new feature of the Globus software that will allow researchers using the Center’s computational and storage resources to easily and securely access and share large data sets with colleagues.
University of California, San Diego bioengineer Karen Christman's new injectable hydrogel, which is designed to repair damaged cardiac tissue following a heart attack, has been licensed to San Diego-based startup Ventrix, Inc, which is planning the first human clinical trials of the technology. Christman is a co-founder of Ventrix.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
